PhRMA lobbies against lower drug prices with $460 million war chest in 2018

The drug industrylobbying group PhRMA registered $460 million of revenue in 2018, a shade more than 2017, according to its latest tax returns obtained by the Center for Responsive Politics.
The bottom line: PhRMA’s influence continues to touch almost every c…
Read More


  • No comments yet.
  • Add a comment